par Blum, David
;Hourez, Raphaël
;Galas, Marie-Christine
;Popoli, Patrizia;Schiffmann, Serge N. 
Référence Lancet neurology, 2, 6, page (366-374)
Publication Publié, 2003-06




Référence Lancet neurology, 2, 6, page (366-374)
Publication Publié, 2003-06
Article révisé par les pairs
Titre: |
|
Auteur: | Blum, David; Hourez, Raphaël; Galas, Marie-Christine; Popoli, Patrizia; Schiffmann, Serge N. |
Informations sur la publication: | Lancet neurology, 2, 6, page (366-374) |
Statut de publication: | Publié, 2003-06 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adenosine -- agonists |
Adenosine -- antagonists & inhibitors | |
Adenosine -- therapeutic use | |
Animals | |
Corpus Striatum -- metabolism | |
Disease Models, Animal | |
Humans | |
Huntington Disease -- drug therapy | |
Huntington Disease -- genetics | |
Huntington Disease -- physiopathology | |
Mitochondrial Diseases -- complications | |
Mitochondrial Diseases -- drug therapy | |
Mitochondrial Diseases -- metabolism | |
Models, Molecular | |
Models, Neurological | |
Mutation | |
Neural Networks (Computer) | |
Neuroprotective Agents -- therapeutic use | |
Receptor, Adenosine A1 -- agonists | |
Receptor, Adenosine A1 -- physiology | |
Receptor, Adenosine A2A -- antagonists & inhibitors | |
Receptor, Adenosine A2A -- physiology | |
Receptors, Dopamine -- metabolism | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:1474-4422 |
info:pii/S1474442203004113 | |
info:pmid/12849153 |